Latest Pulmonology Stories
The COPD Market Will Fracture with the Continuing Entry of LABA/LAMAs and Other Later-to-Market Bronchodilators, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct.
-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct.
On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee.
ORLANDO, Fla., Oct.
AUSTIN, Texas, Oct. 9, 2014 /PRNewswire/ -- International Biophysics Corporation of Austin, Texas announces its filing of U.S. patent protection for its revolutionary AffloVest®.
Emerging Anticytokines, Are Expected to Drive the Market Growth and Open a New Era of Personalized Medicine in Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass.,
RIDGEFIELD, Conn., Oct.
Annual Award from FierceMedicalDevices Names 15 Top Innovative and Market-Disrupting Medical Device Companies IRVINE, Calif., Oct.
Researchers have identified a molecular mechanism that could explain why the common cold can bring on life-threatening asthma attacks.
Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...
- A trick or prank.